Q1 2025 Holdings
Filed 2025-05-15 | 123 holdings | $5.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $1.3B | 17,991,024 | 25.2% |
| Viatris Inc(VTRS) | COM | 92556V106 | $209.0M | 23,991,594 | 4.1% |
| Integra Lifesciences Hldgs C | NOTE 0.500% 8/1 | 457985AM1 | $171.0M | $174,364,000 | 3.4% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $164.7M | 1,489,000 | 3.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $162.2M | 2,671,921 | 3.2% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $155.2M | 11,840,818 | 3.1% |
| Merus N V | COM | N5749R100 | $133.6M | 3,173,928 | 2.6% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $132.3M | 10,514,657 | 2.6% |
| Accolade Inc | NOTE 0.500% 4/0 | 00437EAB8 | $130.6M | $132,598,000 | 2.6% |
| Alnylam Pharmaceuticals Inc | NOTE 1.000% 9/1 | 02043QAB3 | $126.9M | $110,000,000 | 2.5% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $117.3M | 3,317,332 | 2.3% |
| Mirum Pharmaceuticals Inc | NOTE 4.000% 5/0 | 604749AB7 | $114.5M | $70,000,000 | 2.3% |
| Adapthealth Corp(AHCO) | COMMON STOCK | 00653Q102 | $105.3M | 9,711,410 | 2.1% |
| Indivior PLC(INDV) | ORD | G4766E116 | $100.7M | 10,567,160 | 2.0% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $97.7M | 15,612,264 | 1.9% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $85.0M | 4,567,473 | 1.7% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $84.8M | 275,226 | 1.7% |
| Pfizer Inc(PFE) | COM | 717081103 | $84.8M | 3,347,296 | 1.7% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $84.0M | 4,103,957 | 1.7% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $83.0M | 3,422,149 | 1.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $67.3M | 5,191,493 | 1.3% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $65.8M | 1,923,100 | 1.3% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $59.2M | 1,743,555 | 1.2% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $55.1M | 226,070 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $53.5M | 3,267,551 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $45.7M | 2,078,509 | 0.9% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $45.6M | 21,231,974 | 0.9% |
| Enhabit Inc(EHAB) | COM | 29332G102 | $43.9M | 4,997,746 | 0.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $39.2M | 145,000 | 0.8% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $38.9M | 5,189,665 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $38.8M | 782,333 | 0.8% |
| Conmed Corp(CNMD) | COM | 207410101 | $36.9M | 611,000 | 0.7% |
| Lantheus Hldgs Inc | NOTE 2.625%12/1 | 516544AB9 | $35.6M | $25,255,000 | 0.7% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $35.0M | 2,024,943 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $34.9M | 458,000 | 0.7% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $34.7M | 2,720,535 | 0.7% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $32.1M | 3,771,342 | 0.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $31.7M | 2,017,464 | 0.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $29.2M | 3,860,839 | 0.6% |
| Inmode LTD(INMD) | SHS | M5425M103 | $28.0M | 1,578,708 | 0.6% |
| Phreesia Inc(PHR) | COM | 71944F106 | $25.8M | 1,009,844 | 0.5% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $25.2M | 1,050,000 | 0.5% |
| Immunocore Hldgs PLC | NOTE 2.500% 2/0 | 45258DAB1 | $25.2M | $30,000,000 | 0.5% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $23.8M | 1,616,778 | 0.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $23.5M | 2,960,740 | 0.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $23.5M | 619,931 | 0.5% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $23.4M | 240,218 | 0.5% |
| Savara Inc(SVRA) | COM | 805111101 | $22.1M | 7,964,000 | 0.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $20.8M | 850,695 | 0.4% |
| Establishment Labs Hldgs Inc(ESTA)Put | COM | G31249108 | $20.4M | 500,000 | 0.4% |